The	O
involvement	O
of	O
multiple	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
(	I-protein
TNFR	I-protein
)	I-protein
-associated	I-protein
factors	I-protein
in	O
the	O
signaling	O
mechanisms	O
of	O
receptor	B-protein
activator	I-protein
of	O
NF-kappaB	B-protein
,	O
a	O
member	O
of	O
the	O
TNFR	B-protein
superfamily	I-protein
.	O

Receptor	B-protein
activator	I-protein
of	I-protein
NF-kappaB	I-protein
(	O
RANK	B-protein
)	O
is	O
a	O
recently	O
identified	O
member	O
of	O
the	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
superfamily	I-protein
and	O
is	O
expressed	O
on	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
dendritic	B-cell_type
cells	I-cell_type
.	O

Its	O
cognate	B-protein
ligand	I-protein
(	O
RANKL	B-protein
)	O
plays	O
significant	O
roles	O
in	O
the	O
activation	O
of	O
dendritic	O
cell	O
function	O
and	O
osteoclast	O
differentiation	O
.	O

We	O
demonstrate	O
here	O
the	O
interaction	O
of	O
RANK	B-protein
with	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor-associated	I-protein
factors	I-protein
(	I-protein
TRAFs	I-protein
)	I-protein
1	I-protein
,	I-protein
2	I-protein
,	I-protein
3	I-protein
,	I-protein
5	I-protein
,	I-protein
and	I-protein
6	I-protein
both	O
in	O
vitro	O
and	O
in	O
cells	O
.	O

Mapping	O
of	O
the	O
structural	O
requirements	O
for	O
TRAF	B-protein
/RANK	B-protein
interaction	O
revealed	O
multiple	O
TRAF	B-protein
binding	I-protein
sites	I-protein
clustered	O
in	O
two	O
distinct	O
domains	O
in	O
the	O
RANK	B-protein
cytoplasmic	I-protein
tail	I-protein
.	O

These	O
TRAF	B-protein
binding	I-protein
domains	I-protein
were	O
shown	O
to	O
be	O
functionally	O
important	O
for	O
the	O
RANK	B-protein
-dependent	O
induction	O
of	O
NF-kappaB	B-protein
and	O
c-Jun	B-protein
NH2-terminal	B-protein
kinase	I-protein
activities	O
.	O

Site-directed	O
mutagenesis	O
demonstrated	O
that	O
these	O
TRAF	B-protein
binding	I-protein
sites	I-protein
exhibited	O
selective	O
binding	O
for	O
different	O
TRAF	B-protein
proteins	I-protein
.	O

In	O
particular	O
,	O
TRAF6	B-protein
interacted	O
with	O
membrane-proximal	B-protein
determinants	I-protein
distinct	O
from	O
those	O
binding	O
TRAFs	B-protein
1	I-protein
,	I-protein
2	I-protein
,	I-protein
3	I-protein
,	I-protein
and	I-protein
5	I-protein
.	O

When	O
this	O
membrane-proximal	B-protein
TRAF6	I-protein
interaction	I-protein
domain	I-protein
was	O
deleted	O
,	O
RANK	B-protein
-mediated	O
NF-kappaB	B-protein
signaling	O
was	O
completely	O
inhibited	O
while	O
c-Jun	B-protein
NH2-terminal	I-protein
kinase	I-protein
activation	O
was	O
partially	O
inhibited	O
.	O

An	O
NH2-terminal	B-protein
truncation	I-protein
mutant	I-protein
of	O
TRAF6	B-protein
inhibited	O
RANKL	B-protein
-mediated	O
NF-kappaB	B-protein
activation	O
,	O
but	O
failed	O
to	O
affect	O
constitutive	O
signaling	O
induced	O
by	O
receptor	O
overexpression	O
,	O
revealing	O
a	O
selective	O
role	O
for	O
TRAF6	B-protein
in	O
ligand-induced	O
activation	O
events	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

51	NULL
,	NULL
Issue	NULL
of	NULL
December	NULL
18	NULL
,	NULL
pp	NULL
.	NULL

34120-34127	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Involvement	NULL
of	NULL
Multiple	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor	NULL
(	NULL
TNFR	NULL
)	NULL
-associated	NULL
Factors	NULL
in	NULL
the	NULL
Signaling	NULL
Mechanisms	NULL
of	NULL
Receptor	NULL
Activator	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
Member	NULL
of	NULL
the	NULL
TNFR	NULL
Superfamily*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
1	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
October	NULL
1	NULL
,	NULL
1998	NULL
)	NULL
Laurent	NULL
Mark	NULL
E.	NULL
Tometskot	NULL
,	NULL
Dirk	NULL
M.	NULL
Anderson	NULL
,	NULL
David	NULL
Cosman	NULL
,	NULL
and	NULL
William	NULL
C.	NULL
Dougall§	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Immunex	NULL
Corporation	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98101	NULL
Receptor	NULL
activator	NULL
of	NULL
NF-kB	NULL
(	NULL
RANK	NULL
)	NULL
is	NULL
a	NULL
recently	NULL
identified	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
superfamily	NULL
and	NULL
is	NULL
expressed	NULL
on	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Its	NULL
cognate	NULL
ligand	NULL
(	NULL
RANKL	NULL
)	NULL
plays	NULL
significant	NULL
roles	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
dendritic	NULL
cell	NULL
function	NULL
and	NULL
osteoclast	NULL
differentiation	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
the	NULL
interaction	NULL
of	NULL
RANK	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
recep-tor-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
cells	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
structural	NULL
requirements	NULL
for	NULL
TRAF/RANK	NULL
interaction	NULL
revealed	NULL
multiple	NULL
TRAF	NULL
binding	NULL
sites	NULL
clustered	NULL
in	NULL
two	NULL
distinct	NULL
domains	NULL
in	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

These	NULL
TRAF	NULL
binding	NULL
domains	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
functionally	NULL
important	NULL
for	NULL
the	NULL
RANK-dependent	NULL
induction	NULL
of	NULL
NF-xB	NULL
and	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
activities	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
demonstrated	NULL
that	NULL
these	NULL
TRAF	NULL
binding	NULL
sites	NULL
exhibited	NULL
selective	NULL
binding	NULL
for	NULL
different	NULL
TRAF	NULL
proteins	NULL
.	NULL

In	NULL
partic-ular	NULL
,	NULL
TRAF6	NULL
interacted	NULL
with	NULL
membrane-proximal	NULL
determinants	NULL
distinct	NULL
from	NULL
those	NULL
binding	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
.	NULL

When	NULL
this	NULL
membrane-proximal	NULL
TRAFG6	NULL
interaction	NULL
domain	NULL
was	NULL
deleted	NULL
,	NULL
RANK-mediated	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
was	NULL
completely	NULL
inhibited	NULL
while	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
activation	NULL
was	NULL
partially	NULL
inhibited	NULL
.	NULL

An	NULL
truncation	NULL
mutant	NULL
of	NULL
TRAFG	NULL
inhibited	NULL
RANKL-mediated	NULL
NF-KB	NULL
activation	NULL
,	NULL
but	NULL
failed	NULL
to	NULL
affect	NULL
constitutive	NULL
signaling	NULL
induced	NULL
by	NULL
receptor	NULL
overexpression	NULL
,	NULL
revealing	NULL
a	NULL
selective	NULL
role	NULL
for	NULL
TRAF6	NULL
in	NULL
ligand-induced	NULL
activation	NULL
events	NULL
.	NULL

RANK	NULL
and	NULL
RANK	NULL
ligand	NULL
(	NULL
RANKL	NULL
)	NULL
are	NULL
a	NULL
recently	NULL
described	NULL
cognate	NULL
pair	NULL
of	NULL
the	NULL
TNF	NULL
receptor/ligand	NULL
superfamilies	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
receptor	NULL
(	NULL
RANK	NULL
)	NULL
cDNA	NULL
was	NULL
originally	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
DC	NULL
cDNA	NULL
library	NULL
and	NULL
shows	NULL
the	NULL
highest	NULL
homology	NULL
(	NULL
40	NULL
%	NULL
identity	NULL
within	NULL
the	NULL
extracellular	NULL
domain	NULL
)	NULL
with	NULL
CD40	NULL
among	NULL
TNFR	NULL
family	NULL
members	NULL
.	NULL

Among	NULL
antigen-presenting	NULL
cells	NULL
,	NULL
RANK	NULL
surface	NULL
expression	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
to	NULL
DC	NULL
and	NULL
can	NULL
be	NULL
significantly	NULL
up-regulated	NULL
by	NULL
a	NULL
DC	NULL
activator	NULL
,	NULL
CD40	NULL
ligand	NULL
.	NULL

However	NULL
,	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7	NULL
These	NULL
authors	NULL
have	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Immunex	NULL
Corp.	NULL
,	NULL
51	NULL
University	NULL
St.	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98101	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
206-587-0480	NULL
;	NULL
E-mail	NULL
:	NULL
wdougall	NULL
@	NULL
immunex.com	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
RANK	NULL
,	NULL
receptor	NULL
activator	NULL
of	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
TNFR	NULL
,	NULL
TNF	NULL
receptor	NULL
;	NULL
TRAF	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
;	NULL
RANKL	NULL
,	NULL
RANK	NULL
ligand	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
DC	NULL
,	NULL
dendritic	NULL
cell	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
TBS	NULL
,	NULL
TRAF	NULL
binding	NULL
site	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
IL	NULL
,	NULL
interleu-kin	NULL
;	NULL
MOPS	NULL
,	NULL
4-morpholinepropanesulfonic	NULL
acid	NULL
.	NULL

34120	NULL
RANK	NULL
protein	NULL
expression	NULL
is	NULL
not	NULL
DC-specific	NULL
as	NULL
RANK	NULL
is	NULL
also	NULL
expressed	NULL
on	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
phy-tohemagglutinin	NULL
and	NULL
IL-4	NULL
or	NULL
transforming	NULL
growth	NULL
factor-	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
relatively	NULL
specific	NULL
protein	NULL
expression	NULL
,	NULL
RANK	NULL
mRNA	NULL
is	NULL
broadly	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
including	NULL
skeletal	NULL
muscle	NULL
,	NULL
thymus	NULL
,	NULL
liver	NULL
,	NULL
colon	NULL
,	NULL
adrenal	NULL
gland	NULL
,	NULL
and	NULL
small	NULL
intestine	NULL
.	NULL

The	NULL
discrepancy	NULL
between	NULL
mRNA	NULL
and	NULL
surface	NULL
protein	NULL
expression	NULL
suggests	NULL
complex	NULL
post-transcriptional	NULL
regulatory	NULL
mechanisms	NULL
for	NULL
RANK	NULL
expression	NULL
.	NULL

Cells	NULL
may	NULL
therefore	NULL
express	NULL
RANK	NULL
after	NULL
discrete	NULL
activation	NULL
or	NULL
differentiation	NULL
conditions	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
cognate	NULL
ligand	NULL
for	NULL
RANK	NULL
(	NULL
RANKL	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
direct	NULL
expression	NULL
cloning	NULL
from	NULL
a	NULL
mouse	NULL
CD4	NULL
*	NULL
thymoma	NULL
cell	NULL
line	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
same	NULL
ligand	NULL
has	NULL
also	NULL
been	NULL
identified	NULL
by	NULL
screening	NULL
a	NULL
T	NULL
cell	NULL
hybridoma	NULL
cell	NULL
line	NULL
(	NULL
termed	NULL
TRANCE	NULL
)	NULL
(	NULL
2	NULL
)	NULL
and	NULL
as	NULL
an	NULL
osteoclast	NULL
differentiation	NULL
factor	NULL
(	NULL
3	NULL
)	NULL
whose	NULL
activity	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
soluble	NULL
TNF	NULL
receptor	NULL
family	NULL
member	NULL
,	NULL
osteo-protegerin	NULL
(	NULL
4	NULL
)	NULL
.	NULL

RANKL	NULL
mRNA	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
more	NULL
restricted	NULL
tissue	NULL
expression	NULL
pattern	NULL
than	NULL
RANK	NULL
and	NULL
has	NULL
only	NULL
been	NULL
detected	NULL
in	NULL
mouse	NULL
thymus	NULL
,	NULL
lymph	NULL
node	NULL
,	NULL
spleen	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
bone	NULL
marrow	NULL
stroma	NULL
,	NULL
and	NULL
trabecular	NULL
bone	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Specific	NULL
lymphoid	NULL
cells	NULL
that	NULL
express	NULL
RANKL	NULL
include	NULL
both	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cell	NULL
progenitors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

TCR	NULL
stimulation	NULL
of	NULL
T	NULL
cell	NULL
hybri-domas	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
induction	NULL
of	NULL
RANKL/TRANCE	NULL
mRNA	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
biological	NULL
function	NULL
of	NULL
the	NULL
RANK/RANKL	NULL
interaction	NULL
demonstrate	NULL
that	NULL
RANKL	NULL
promotes	NULL
the	NULL
survival	NULL
of	NULL
transforming	NULL
growth	NULL
factor-B-treated	NULL
T	NULL
cells	NULL
and	NULL
increases	NULL
the	NULL
clustering	NULL
and	NULL
allo-stimulatory	NULL
capacity	NULL
of	NULL
human	NULL
DC	NULL
(	NULL
1	NULL
)	NULL
.	NULL

RANKL	NULL
may	NULL
promote	NULL
DC	NULL
survival	NULL
by	NULL
a	NULL
BCL-X	NULL
;	NULL
,	NULL
-dependent	NULL
mechanism	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
recent	NULL
characterization	NULL
of	NULL
RANKL	NULL
as	NULL
an	NULL
essential	NULL
factor	NULL
for	NULL
osteoclast	NULL
differentiation	NULL
and	NULL
activation	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
demonstrates	NULL
additional	NULL
activities	NULL
of	NULL
RANKL	NULL
on	NULL
myeloid	NULL
lineages	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
RANK	NULL
in	NULL
bone	NULL
resorption/oste-oclast	NULL
differentiation	NULL
has	NULL
not	NULL
been	NULL
elucidated	NULL
,	NULL
RANK	NULL
and	NULL
its	NULL
ligand	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cellVDC	NULL
interactions	NULL
and	NULL
may	NULL
also	NULL
function	NULL
in	NULL
other	NULL
important	NULL
cellular	NULL
differentiation	NULL
processes	NULL
.	NULL

Although	NULL
the	NULL
physiological	NULL
functions	NULL
of	NULL
RANK	NULL
and	NULL
RANKL	NULL
have	NULL
been	NULL
investigated	NULL
,	NULL
the	NULL
mechanisms	NULL
of	NULL
RANK	NULL
signal	NULL
trans-duction	NULL
have	NULL
not	NULL
been	NULL
intensively	NULL
studied	NULL
.	NULL

Multimerization	NULL
of	NULL
TNFR	NULL
family	NULL
members	NULL
(	NULL
as	NULL
a	NULL
result	NULL
of	NULL
ligand	NULL
binding	NULL
or	NULL
receptor	NULL
overexpression	NULL
)	NULL
is	NULL
thought	NULL
to	NULL
lead	NULL
to	NULL
receptor	NULL
activation	NULL
and	NULL
signal	NULL
transduction	NULL
,	NULL
perhaps	NULL
by	NULL
revealing	NULL
binding	NULL
domains	NULL
for	NULL
enzymes	NULL
or	NULL
adaptor	NULL
proteins	NULL
.	NULL

In	NULL
recent	NULL
years	NULL
,	NULL
substantial	NULL
progress	NULL
has	NULL
been	NULL
made	NULL
to	NULL
define	NULL
the	NULL
cytoplasmic	NULL
proteins	NULL
that	NULL
function	NULL
as	NULL
adaptors	NULL
(	NULL
TRAFs	NULL
1-6	NULL
,	NULL
TRADD	NULL
,	NULL
FADD	NULL
)	NULL
or	NULL
as	NULL
serine/	NULL
threonine	NULL
kinases	NULL
(	NULL
RIP	NULL
)	NULL
and	NULL
link	NULL
TNF	NULL
receptor	NULL
stimulation	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
,	NULL
Jun	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
pathways	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

6	NULL
)	NULL
.	NULL

RANK	NULL
stimulation	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
transcription	NULL
complex	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
RANK-expressing	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
transfected	NULL
293	NULL
cells	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
(	NULL
1	NULL
)	NULL
and	NULL
JNK	NULL
(	NULL
2	NULL
)	NULL
in	NULL
mouse	NULL
thymocytes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
determinants	NULL
or	NULL
the	NULL
cytoplasmic	NULL
effector/adaptor	NULL
proteins	NULL
necessary	NULL
for	NULL
downstream	NULL
signaling	NULL
have	NULL
not	NULL
been	NULL
described	NULL
.	NULL

While	NULL
the	NULL
383-amino	NULL
acid	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
RANK	NULL
is	NULL
the	NULL
largest	NULL
of	NULL
any	NULL
known	NULL
TNFR	NULL
,	NULL
it	NULL
does	NULL
not	NULL
contain	NULL
sequences	NULL
suggestive	NULL
of	NULL
catalytic	NULL
activity	NULL
or	NULL
significant	NULL
homology	NULL
with	NULL
any	NULL
known	NULL
protein	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
RANK	NULL
cytoplasmic	NULL
domains	NULL
include	NULL
multiple	NULL
sections	NULL
that	NULL
show	NULL
striking	NULL
homology	NULL
(	NULL
64	NULL
%	NULL
amino	NULL
acid	NULL
identity	NULL
and	NULL
78	NULL
%	NULL
similarity	NULL
)	NULL
between	NULL
species	NULL
(	NULL
1	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
conserved	NULL
functional	NULL
role	NULL
for	NULL
these	NULL
structures	NULL
.	NULL

Since	NULL
many	NULL
members	NULL
of	NULL
the	NULL
TNFR	NULL
superfamily	NULL
that	NULL
do	NULL
not	NULL
contain	NULL
a	NULL
death	NULL
domain	NULL
(	NULL
p80	NULL
TNFR	NULL
,	NULL
CD40	NULL
,	NULL
CD30	NULL
,	NULL
CD27	NULL
,	NULL
OX40	NULL
,	NULL
4-1BB	NULL
,	NULL
LTGBR	NULL
,	NULL
HVEM	NULL
)	NULL
interact	NULL
with	NULL
the	NULL
cytoplasmic	NULL
adaptor/effector	NULL
TRAF	NULL
proteins	NULL
(	NULL
7-13	NULL
)	NULL
,	NULL
we	NULL
designed	NULL
an	NULL
approach	NULL
to	NULL
experimentally	NULL
define	NULL
TRAF	NULL
binding	NULL
to	NULL
RANK	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
identified	NULL
the	NULL
structural	NULL
and	NULL
functional	NULL
features	NULL
of	NULL
RANK	NULL
required	NULL
for	NULL
both	NULL
NF-kB	NULL
and	NULL
JNK-mediated	NULL
signaling	NULL
.	NULL

Our	NULL
analysis	NULL
delineates	NULL
multiple	NULL
distinct	NULL
and	NULL
independent	NULL
domains	NULL
capable	NULL
of	NULL
binding	NULL
TRAF	NULL
proteins	NULL
and	NULL
transmitting	NULL
downstream	NULL
signals	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TRAF6	NULL
appears	NULL
to	NULL
mediate	NULL
RANK	NULL
function	NULL
through	NULL
unique	NULL
determinants	NULL
independent	NULL
of	NULL
other	NULL
TRAF	NULL
proteins	NULL
and	NULL
plays	NULL
a	NULL
selective	NULL
role	NULL
in	NULL
RANKL-induced	NULL
signaling	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Production	NULL
and	NULL
Purification	NULL
of	NULL
GST	NULL
Fusion	NULL
Proteins-Deletion	NULL
constructs	NULL
of	NULL
RANK	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
,	NULL
and	NULL
point	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
primers	NULL
containing	NULL
the	NULL
appropriate	NULL
nucleotide	NULL
substitutions	NULL
.	NULL

The	NULL
appropriate	NULL
inserts	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pGEX-4T	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
vector	NULL
at	NULL
the	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
.	NULL

The	NULL
correct	NULL
sequence	NULL
of	NULL
each	NULL
of	NULL
the	NULL
PCR-generated	NULL
inserts	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

A	NULL
GST-human	NULL
FAS	NULL
cytoplasmic	NULL
domain	NULL
construct	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specificity	NULL
control	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
were	NULL
expressed	NULL
and	NULL
purified	NULL
from	NULL
Escherichia	NULL
coli	NULL
by	NULL
glutathione-aga-rose	NULL
affinity	NULL
media	NULL
according	NULL
to	NULL
published	NULL
procedures	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Fusion	NULL
protein	NULL
concentrations	NULL
of	NULL
0.5-2.5	NULL
mg/ml	NULL
were	NULL
typically	NULL
obtained	NULL
.	NULL

In	NULL
Vitro	NULL
Protein	NULL
Binding	NULL
Assay-Full-length	NULL
TRAF	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
pGEM-T	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
vectors	NULL
.	NULL

RNA	NULL
was	NULL
generated	NULL
in	NULL
vitro	NULL
with	NULL
either	NULL
T7	NULL
or	NULL
T3	NULL
polymerase	NULL
using	NULL
the	NULL
Ambion	NULL
(	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
mMessage	NULL
Machine	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
translated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
°*°S	NULL
)	NULL
methionine/cysteine	NULL
using	NULL
25	NULL
ul	NULL
of	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
TNT-coupled	NULL
Reticulocyte	NULL
Lysate	NULL
Systems	NULL
,	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
the	NULL
protein	NULL
product	NULL
was	NULL
determined	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
relative	NULL
protein	NULL
amounts	NULL
were	NULL
normalized	NULL
after	NULL
image	NULL
analysis	NULL
using	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
(	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
Storm	NULL
860	NULL
optical	NULL
scanner	NULL
.	NULL

Proteins	NULL
were	NULL
diluted	NULL
into	NULL
binding	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
0.25	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
precleared	NULL
by	NULL
overnight	NULL
incubation	NULL
with	NULL
100	NULL
ug	NULL
of	NULL
glutathione-Sepharose	NULL
4B	NULL
beads	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

For	NULL
each	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
,	NULL
translated	NULL
protein	NULL
was	NULL
combined	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
appropriate	NULL
GST	NULL
fusion	NULL
protein	NULL
complexed	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
and	NULL
incubated	NULL
with	NULL
rotation	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
protein	NULL
complexes	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
binding	NULL
buffer	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Gels	NULL
were	NULL
stained	NULL
with	NULL
Coomassie	NULL
Blue	NULL
to	NULL
confirm	NULL
equal	NULL
loading	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
,	NULL
treated	NULL
with	NULL
Amplify	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
fluorography	NULL
for	NULL
6-24	NULL
h.	NULL
Cell	NULL
Transfection	NULL
and	NULL
Reporter	NULL
Assays-A	NULL
NF-	NULL
«	NULL
B-responsive	NULL
reporter	NULL
plasmid	NULL
was	NULL
constructed	NULL
in	NULL
pGL2-Basic	NULL
(	NULL
Promega	NULL
)	NULL
with	NULL
the	NULL
human	NULL
IL-8	NULL
promoter	NULL
containing	NULL
a	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
15	NULL
)	NULL
fused	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
.	NULL

293/EBNA	NULL
cells	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
full-length	NULL
human	NULL
RANK	NULL
cDNA	NULL
in	NULL
pDC304	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Full-length	NULL
and	NULL
deletion	NULL
constructs	NULL
of	NULL
TRAF	NULL
cDNAs	NULL
(	NULL
with	NULL
an	NULL
in-frame	NULL
NH	NULL
,	NULL
-terminal	NULL
FLAG	NULL
tag	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
and	NULL
cloned	NULL
into	NULL
pDC304	NULL
.	NULL

The	NULL
TRAF2	NULL
NH	NULL
,	NULL
-terminal	NULL
deletion	NULL
(	NULL
TRAF2-	NULL
(	NULL
87-501	NULL
)	NULL
)	NULL
removed	NULL
the	NULL
first	NULL
86	NULL
amino	NULL
acids	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

17	NULL
)	NULL
.	NULL

The	NULL
zinc-ring	NULL
truncation	NULL
of	NULL
TRAF5-	NULL
(	NULL
284-558	NULL
)	NULL
was	NULL
constructed	NULL
similarly	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
TRAF6	NULL
construct	NULL
truncated	NULL
the	NULL
zinc	NULL
ring	NULL
and	NULL
each	NULL
of	NULL
the	NULL
zinc	NULL
fingers	NULL
(	NULL
TRAF6G-	NULL
(	NULL
289-522	NULL
)	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
B-galactosidase-expressing	NULL
plasmid	NULL
(	NULL
pDC304/LACZ	NULL
;	NULL
25	NULL
ng/well	NULL
)	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Total	NULL
DNA	NULL
concentrations	NULL
for	NULL
each	NULL
transfection	NULL
were	NULL
equalized	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
34121	NULL
empty	NULL
pDC304	NULL
vector	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
recombinant	NULL
human	NULL
RANKL	NULL
for	NULL
16	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Recombinant	NULL
human	NULL
RANKL	NULL
is	NULL
an	NULL
fusion	NULL
of	NULL
a	NULL
leucine	NULL
zipper	NULL
trimerization	NULL
domain	NULL
(	NULL
20	NULL
)	NULL
with	NULL
residues	NULL
138-317	NULL
of	NULL
RANKL	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
in	NULL
cell	NULL
lysates	NULL
was	NULL
measured	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
)	NULL
using	NULL
a	NULL
EG	NULL
&	NULL
G/Berthold	NULL
luminometer	NULL
.	NULL

Relative	NULL
luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
298	NULL
cells	NULL
transfected	NULL
with	NULL
full-length	NULL
or	NULL
cytoplasmic	NULL
truncations	NULL
of	NULL
RANK	NULL
or	NULL
control	NULL
vector	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
an	NULL
NF-kB	NULL
binding	NULL
site	NULL
were	NULL
annealed	NULL
,	NULL
radiolabeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
PIATP	NULL
and	NULL
combined	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
reaction	NULL
was	NULL
confirmed	NULL
by	NULL
competition	NULL
with	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
non-labeled	NULL
wild-type	NULL
oligonucleotides	NULL
or	NULL
oligonucleotides	NULL
containing	NULL
a	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
6	NULL
%	NULL
PAGE	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
buffer	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Protein	NULL
Kinase	NULL
Assays-For	NULL
JNK	NULL
assays	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
298	NULL
cells	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
my	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
50	NULL
mM	NULL
B-glycerol	NULL
phosphate	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
the	NULL
protease	NULL
inhibitors	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
and	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

Clarified	NULL
lysates	NULL
were	NULL
immunopre-cipitated	NULL
with	NULL
1	NULL
ug	NULL
each	NULL
of	NULL
anti-JNK	NULL
(	NULL
FL	NULL
)	NULL
and	NULL
anti-JNK	NULL
(	NULL
C17	NULL
)	NULL
(	NULL
both	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
two	NULL
times	NULL
with	NULL
wash	NULL
buffer	NULL
(	NULL
500	NULL
mM	NULL
LiCl	NULL
,	NULL
100	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
and	NULL
three	NULL
times	NULL
in	NULL
assay	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
MOPS	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
an	NULL
immune-complex	NULL
assay	NULL
using	NULL
1	NULL
ug	NULL
of	NULL
GST	NULL
-c-Jun-	NULL
(	NULL
1-169	NULL
)	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
5	NULL
Ci	NULL
of	NULL
[	NULL
®PJATP	NULL
as	NULL
substrate	NULL
in	NULL
40	NULL
ul	NULL
of	NULL
assay	NULL
buffer	NULL
at	NULL
80	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
4-20	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Interaction	NULL
of	NULL
the	NULL
RANK	NULL
Cytoplasmic	NULL
Domain	NULL
with	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6-In	NULL
order	NULL
to	NULL
define	NULL
whether	NULL
TRAFs	NULL
may	NULL
bind	NULL
to	NULL
RANK	NULL
,	NULL
each	NULL
of	NULL
the	NULL
known	NULL
TRAFs	NULL
was	NULL
transcribed	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
3SS	NULL
]	NULL
methionine/cysteine	NULL
and	NULL
coprecipitation	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
interaction	NULL
with	NULL
a	NULL
GST	NULL
fusion	NULL
expressing	NULL
the	NULL
full-length	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

This	NULL
domain	NULL
(	NULL
RANK	NULL
amino	NULL
acids	NULL
206-616	NULL
)	NULL
was	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
in	NULL
a	NULL
specific	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
strong	NULL
binding	NULL
of	NULL
RANK	NULL
with	NULL
TRAF	NULL
's	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
;	NULL
weak	NULL
interaction	NULL
with	NULL
TRAF5	NULL
;	NULL
and	NULL
no	NULL
binding	NULL
with	NULL
TRAFA4	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
none	NULL
of	NULL
the	NULL
TRAFs	NULL
interacted	NULL
with	NULL
a	NULL
control	NULL
GST	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
or	NULL
a	NULL
GST-FAS	NULL
cytoplasmic	NULL
domain	NULL
fusion	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
#	NULL
7	NULL
vitro	NULL
interaction	NULL
of	NULL
TRAF	NULL
's	NULL
with	NULL
RANK	NULL
also	NULL
occurred	NULL
in	NULL
cells	NULL
,	NULL
co-immunoprecipitation	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
293	NULL
cells	NULL
cotransfected	NULL
with	NULL
RANK	NULL
and	NULL
epitope-tagged	NULL
TRAFs	NULL
and	NULL
revealed	NULL
that	NULL
full-length	NULL
RANK	NULL
associated	NULL
with	NULL
the	NULL
same	NULL
repertoire	NULL
of	NULL
TRAFs	NULL
(	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
but	NULL
not	NULL
TRAFA4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
four	NULL
individual	NULL
COOH-terminal	NULL
deletions	NULL
were	NULL
constructed	NULL
and	NULL
the	NULL
in	NULL
vitro	NULL
binding	NULL
assays	NULL
were	NULL
repeated	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
full-length	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
a	NULL
deletion	NULL
construct	NULL
that	NULL
lacks	NULL
the	NULL
COOH-terminal	NULL
72	NULL
amino	NULL
acids	NULL
(	NULL
RANK	NULL
A544	NULL
)	NULL
was	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
and	NULL
TRAF6	NULL
binding	NULL
was	NULL
reduced	NULL
by	NULL
approximately	NULL
50	NULL
%	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
an	NULL
additional	NULL
68	NULL
amino	NULL
acids	NULL
(	NULL
RANK	NULL
A476	NULL
)	NULL
or	NULL
123	NULL
amino	NULL
acids	NULL
(	NULL
RANK	NULL
A421	NULL
)	NULL
showed	NULL
no	NULL
difference	NULL
in	NULL
TRAF6	NULL
binding	NULL
activity	NULL
relative	NULL
to	NULL
RANK	NULL
206-544	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
COOH-terminal	NULL
277	NULL
amino	NULL
acids	NULL
were	NULL
deleted	NULL
(	NULL
RANK	NULL
A339	NULL
)	NULL
,	NULL
the	NULL
remaining	NULL
interaction	NULL
with	NULL
TRAF6	NULL
was	NULL
lost	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
two	NULL
separate	NULL
regions	NULL
of	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
are	NULL
each	NULL
capable	NULL
of	NULL
binding	NULL
TRAF	NULL
proteins	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
protein	NULL
sequence	NULL
within	NULL
the	NULL
COOH-terminal	NULL
72-amino	NULL
acid	NULL
RANK	NULL
domain	NULL
capable	NULL
of	NULL
TRAF	NULL
binding	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
34122	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Interaction	NULL
of	NULL
TRAFs	NULL
with	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
region	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
RANK	NULL
cytoplasmic	NULL
mutant	NULL
constructs	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
positions	NULL
of	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
RANK	NULL
are	NULL
shown	NULL
for	NULL
the	NULL
full-length	NULL
RANK	NULL
beginning	NULL
at	NULL
residue	NULL
206	NULL
.	NULL

The	NULL
stippled	NULL
box	NULL
from	NULL
amino	NULL
acid	NULL
218	NULL
to	NULL
233	NULL
represents	NULL
the	NULL
transmembrane	NULL
region	NULL
,	NULL
and	NULL
the	NULL
shaded	NULL
boxes	NULL
marked	NULL
with	NULL
Roman	NULL
numerals	NULL
I	NULL
,	NULL
II	NULL
,	NULL
and	NULL
III	NULL
represent	NULL
putative	NULL
TRAF	NULL
binding	NULL
sites	NULL
as	NULL
discussed	NULL
under	NULL
``	NULL
Results	NULL
.	NULL
``	NULL

The	NULL
COOH-terminal	NULL
deletions	NULL
(	NULL
RANK	NULL
A	NULL
constructs	NULL
)	NULL
are	NULL
shown	NULL
,	NULL
including	NULL
the	NULL
position	NULL
of	NULL
the	NULL
COOH-terminal	NULL
amino	NULL
acid	NULL
.	NULL

The	NULL
constructs	NULL
containing	NULL
point	NULL
mutations	NULL
are	NULL
described	NULL
with	NULL
the	NULL
amino	NULL
acid	NULL
substitutions	NULL
above	NULL
the	NULL
putative	NULL
TRAF	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
RANK	NULL
A840-421	NULL
mutation	NULL
is	NULL
an	NULL
internal	NULL
in-frame	NULL
deletion	NULL
of	NULL
residues	NULL
340-420	NULL
including	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
I	NULL
.	NULL

These	NULL
mutants	NULL
were	NULL
expressed	NULL
either	NULL
in	NULL
bacteria	NULL
as	NULL
GST	NULL
fusion	NULL
proteins	NULL
with	NULL
the	NULL
RANK	NULL
sequence	NULL
beginning	NULL
at	NULL
position	NULL
206	NULL
or	NULL
in	NULL
mammalian	NULL
cells	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
remaining	NULL
NH	NULL
,	NULL
-terminal	NULL
RANK	NULL
se-quence	NULL
.	NULL

B	NULL
,	NULL
TRAF	NULL
binding	NULL
to	NULL
RANK	NULL
was	NULL
measured	NULL
by	NULL
incubating	NULL
purified	NULL
GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
and	NULL
COOH-terminal	NULL
RANK	NULL
deletions	NULL
)	NULL
separately	NULL
with	NULL
TRAF	NULL
proteins	NULL
1-6	NULL
translated	NULL
in	NULL
vitro	NULL
with	NULL
[	NULL
®°S	NULL
)	NULL
methionine/cysteine	NULL
.	NULL

Bound	NULL
complexes	NULL
were	NULL
precipitated	NULL
with	NULL
glutathi-one-agarose	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
fluorography	NULL
.	NULL

A	NULL
fraction	NULL
of	NULL
the	NULL
labeled	NULL
input	NULL
protein	NULL
(	NULL
2	NULL
%	NULL
)	NULL
has	NULL
also	NULL
been	NULL
directly	NULL
run	NULL
on	NULL
the	NULL
gel	NULL
.	NULL

As	NULL
a	NULL
specificity	NULL
control	NULL
,	NULL
GST	NULL
beads	NULL
were	NULL
also	NULL
incubated	NULL
with	NULL
labeled	NULL
TRAFs	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
used	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
,	NULL
and	NULL
equal	NULL
loading	NULL
of	NULL
lanes	NULL
was	NULL
confirmed	NULL
by	NULL
visualization	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
R-250	NULL
staining	NULL
.	NULL

revealed	NULL
multiple	NULL
regions	NULL
with	NULL
limited	NULL
homology	NULL
with	NULL
experimentally	NULL
defined	NULL
TRAF	NULL
binding	NULL
sites	NULL
(	NULL
TBS	NULL
)	NULL
in	NULL
other	NULL
TNFR	NULL
family	NULL
members	NULL
.	NULL

We	NULL
defined	NULL
two	NULL
potential	NULL
RANK	NULL
TBS	NULL
in	NULL
this	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
A	NULL
RANK	NULL
full-length	NULL
RANK	NULL
A544	NULL
RANK	NULL
A476	NULL
RANK	NULL
A421	NULL
RANK	NULL
A339	NULL
(	NULL
QEE-	NULL
>	NULL
AAA	NULL
)	NULL
RANK	NULL
571-573	NULL
(	NULL
QEE-	NULL
>	NULL
AAA	NULL
)	NULL
RANK	NULL
609-610	NULL
(	NULL
QE-	NULL
>	NULL
AA	NULL
)	NULL
206	NULL
616	NULL
RANK	NULL
571-573	NULL
(	NULL
QEE-	NULL
>	NULL
AAA	NULL
)	NULL
+	NULL
609-610	NULL
(	NULL
QE-	NULL
>	NULL
AA	NULL
)	NULL
339/422	NULL
RANK	NULL
A340-421	NULL
-79	NULL
TRAFG	NULL
«	NULL
muh	NULL
come	NULL
que	NULL
-40	NULL
-31	NULL
(	NULL
kDa	NULL
)	NULL
(	NULL
kDa	NULL
)	NULL
region	NULL
(	NULL
residues	NULL
569-574	NULL
(	NULL
P-V-Q-E-E-T	NULL
)	NULL
and	NULL
residues	NULL
607-611	NULL
(	NULL
P-V-Q-E-Q	NULL
)	NULL
)	NULL
due	NULL
to	NULL
their	NULL
similarity	NULL
to	NULL
the	NULL
P-X-Q-X-T	NULL
TBS	NULL
found	NULL
in	NULL
CD40	NULL
and	NULL
CD30	NULL
(	NULL
22	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
HVEM	NULL
TBS	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
Y	NULL
~	NULL
>	NULL
Y	NULL
45	NULL
?	NULL

x	NULL
I	NULL
¢	NULL
§	NULL
&	NULL
£0	NULL
um	NULL
S0	NULL
my	NULL
b	NULL
m	NULL
~.0	NULL
Jr	NULL
dG	NULL
-	NULL
S	NULL
S	NULL
S	NULL
Ss	NULL
§	NULL
-	NULL
&	NULL
&	NULL
48	NULL
F	NULL
TRAF	NULL
1	NULL
Cope	NULL
Cp	NULL
«	NULL
ca	NULL
TRAF2	NULL
wiz	NULL
gos	NULL
TRAF3	NULL
TRAFS5	NULL
--	NULL
»	NULL
«	NULL
saan	NULL
.	NULL

TRAFG	NULL
--	NULL
>	NULL
Cue	NULL
-	NULL
.	NULL

,	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Mapping	NULL
of	NULL
critical	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
RANK	NULL
for	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
TRAF3	NULL
,	NULL
TRAF5	NULL
,	NULL
and	NULL
TRAF6	NULL
binding	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
with	NULL
different	NULL
RANK	NULL
mutations	NULL
were	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
binding	NULL
assays	NULL
with	NULL
radiolabeled	NULL
TRAF	NULL
proteins	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
alanine	NULL
substitutions	NULL
were	NULL
made	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
full-length	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
residues	NULL
206-616	NULL
)	NULL
.	NULL

The	NULL
position	NULL
and	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
mutated	NULL
residues	NULL
in	NULL
RANK	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
V-E-E-T	NULL
)	NULL
(	NULL
9	NULL
)	NULL
and	NULL
the	NULL
OX40	NULL
TBS	NULL
(	NULL
P-I-Q-E-E	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
these	NULL
residues	NULL
in	NULL
RANK	NULL
were	NULL
important	NULL
for	NULL
TRAF	NULL
binding	NULL
,	NULL
we	NULL
substituted	NULL
certain	NULL
amino	NULL
acids	NULL
within	NULL
these	NULL
putative	NULL
TBS	NULL
with	NULL
alanine	NULL
and	NULL
assayed	NULL
TRAF	NULL
binding	NULL
.	NULL

Mutagenesis	NULL
of	NULL
amino	NULL
acids	NULL
609-610	NULL
(	NULL
Q-E	NULL
)	NULL
to	NULL
alanine	NULL
within	NULL
the	NULL
full-length	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
significantly	NULL
abolished	NULL
TRAF1I	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF5	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
GST-RANK	NULL
A544	NULL
deletion	NULL
.	NULL

Binding	NULL
of	NULL
TRAF3	NULL
and	NULL
TRAF6	NULL
were	NULL
unaffected	NULL
.	NULL

Substitution	NULL
of	NULL
residues	NULL
571-573	NULL
(	NULL
Q-E-E	NULL
)	NULL
with	NULL
alanine	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
TRAF3	NULL
binding	NULL
without	NULL
reducing	NULL
the	NULL
binding	NULL
of	NULL
any	NULL
other	NULL
TRAF	NULL
.	NULL

These	NULL
results	NULL
identify	NULL
two	NULL
separate	NULL
regions	NULL
critical	NULL
for	NULL
binding	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
.	NULL

By	NULL
combining	NULL
mutations	NULL
of	NULL
these	NULL
two	NULL
sites	NULL
(	NULL
571-573	NULL
and	NULL
609-610	NULL
)	NULL
,	NULL
loss	NULL
of	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
binding	NULL
was	NULL
more	NULL
pronounced	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
two	NULL
sites	NULL
cooperate	NULL
in	NULL
binding	NULL
.	NULL

None	NULL
of	NULL
the	NULL
mutations	NULL
examined	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
reduced	NULL
TRAF6	NULL
binding	NULL
,	NULL
indicating	NULL
that	NULL
TRAF6	NULL
recognizes	NULL
distinct	NULL
TBS	NULL
in	NULL
RANK	NULL
.	NULL

RANK	NULL
Stimulation	NULL
Induces	NULL
the	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B-We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
activation	NULL
of	NULL
RANK	NULL
either	NULL
by	NULL
receptor	NULL
overexpression	NULL
or	NULL
by	NULL
RANKL	NULL
treatment	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
RANK	NULL
cytoplasmic	NULL
sequences	NULL
and	NULL
other	NULL
cellular	NULL
protein	NULL
effec-tors	NULL
in	NULL
RANK	NULL
signaling	NULL
,	NULL
we	NULL
established	NULL
a	NULL
transient	NULL
transfec-tion/NF-	NULL
«	NULL
B-responsive	NULL
reporter	NULL
system	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
reporter	NULL
activity	NULL
resulting	NULL
from	NULL
increased	NULL
RANK	NULL
expression	NULL
in	NULL
the	NULL
293	NULL
cells	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
reporter	NULL
activity	NULL
increased	NULL
in	NULL
a	NULL
34123	NULL
A	NULL
40	NULL
,	NULL
30	NULL
4	NULL
aam	NULL
20	NULL
4	NULL
(	NULL
5	NULL
0	NULL
B3	NULL
O	NULL
3	NULL
10	NULL
ke	NULL
]	NULL
.E	NULL
GC	NULL
``	NULL
O	NULL
0	NULL
5	NULL
w=	NULL
RANKDNA	NULL
|	NULL
u	NULL
-	NULL
t	NULL
0	NULL
To	NULL
s	NULL
-so	NULL
©	NULL
@	NULL
-	NULL
(	NULL
ngiweln	NULL
_	NULL
3	NULL
°	NULL
9°	NULL
c=	NULL
®	NULL
``	NULL
g	NULL
_	NULL
»	NULL
o	NULL
&	NULL
B	NULL
@	NULL
©	NULL
'	NULL
i	NULL
Nes	NULL
»	NULL
ao	NULL
-b-	NULL
3	NULL
O	NULL
©	NULL
20	NULL
4	NULL
o	NULL
D	NULL
h	NULL
ber	NULL
&	NULL
10	NULL
fs	NULL
3	NULL
wal	NULL
0.	NULL
z	NULL
]	NULL
RANK	NULL
(	NULL
O	NULL
.4	NULL
)	NULL
=	NULL
=	NULL
+	NULL
+	NULL
+	NULL
SSIRANKL	NULL
(	NULL
SO	NULL
)	NULL
-	NULL
-	NULL
+	NULL
-~	NULL
+	NULL
@	NULL
@	NULL
lmRanKL	NULL
(	NULL
500	NULL
)	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
_+	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
activated	NULL
by	NULL
overexpression	NULL
of	NULL
RANK	NULL
or	NULL
by	NULL
RANKL	NULL
treatment	NULL
of	NULL
RANK	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
overexpression	NULL
of	NULL
RANK	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Expression	NULL
vectors	NULL
containing	NULL
RANK	NULL
(	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
NF-	NULL
«	NULL
B-responsive	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
IL-8/	NULL
REP	NULL
)	NULL
and	NULL
pDC304/LACZ	NULL
into	NULL
298	NULL
cells	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Relative	NULL
luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
expression	NULL
levels	NULL
and	NULL
are	NULL
reported	NULL
as	NULL
mean	NULL
values	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
triplicate	NULL
transfections	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
soluble	NULL
and	NULL
transmembrane	NULL
forms	NULL
of	NULL
RANKL	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
RANK	NULL
transfected	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
co-transfected	NULL
with	NULL
RANK	NULL
expression	NULL
vector	NULL
(	NULL
0.4	NULL
ng	NULL
)	NULL
,	NULL
NF-kB	NULL
responsive	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
pIL-8/REP	NULL
)	NULL
,	NULL
and	NULL
pDC304/6-galactosidase	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
for	NULL
18	NULL
h	NULL
with	NULL
500	NULL
ng/m	NULL
!	NULL

soluble	NULL
recombinant	NULL
human	NULL
RANKL-leucine	NULL
zipper	NULL
(	NULL
rhRANKL	NULL
)	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
activity	NULL
of	NULL
transmembrane	NULL
ligand	NULL
expression	NULL
on	NULL
RANK-mediated	NULL
reporter	NULL
activity	NULL
,	NULL
cells	NULL
were	NULL
also	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
full-length	NULL
RANKL	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
transmembrane	NULL
ligand	NULL
had	NULL
no	NULL
significant	NULL
affect	NULL
on	NULL
reporter	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
transfected	NULL
receptors	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RANK	NULL
dose-dependent	NULL
manner	NULL
until	NULL
optimal	NULL
(	NULL
30-fold	NULL
)	NULL
induction	NULL
was	NULL
achieved	NULL
with	NULL
6.4	NULL
ng	NULL
of	NULL
RANK	NULL
DNA	NULL
transfected	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
illustrate	NULL
that	NULL
ectopic	NULL
overexpression	NULL
of	NULL
RANK	NULL
can	NULL
lead	NULL
to	NULL
ligand-independent	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
other	NULL
TNFR	NULL
family	NULL
members	NULL
,	NULL
p80	NULL
TNFR	NULL
and	NULL
CD40	NULL
(	NULL
7	NULL
,	NULL
23	NULL
)	NULL
.	NULL

RANKL-dependent	NULL
signaling	NULL
was	NULL
next	NULL
examined	NULL
by	NULL
the	NULL
transfection/reporter	NULL
system	NULL
using	NULL
a	NULL
suboptimal	NULL
RANK	NULL
DNA	NULL
concentration	NULL
(	NULL
0.4	NULL
ng/transfection	NULL
)	NULL
.	NULL

Co-transfection	NULL
of	NULL
RANK	NULL
and	NULL
the	NULL
transmembrane	NULL
form	NULL
of	NULL
RANKL	NULL
stimulated	NULL
the	NULL
NF-	NULL
«	NULL
B-reporter	NULL
more	NULL
than	NULL
that	NULL
seen	NULL
after	NULL
transfection	NULL
with	NULL
RANK	NULL
only	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

We	NULL
also	NULL
demonstrated	NULL
that	NULL
soluble	NULL
RANKL	NULL
protein	NULL
enhanced	NULL
reporter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
of	NULL
RANK	NULL
overexpression	NULL
or	NULL
RANKL	NULL
treatment	NULL
were	NULL
also	NULL
seen	NULL
with	NULL
a	NULL
minimal	NULL
NF-kB	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
confirming	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
34124	NULL
that	NULL
these	NULL
responses	NULL
are	NULL
due	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Is	NULL
Mediated	NULL
by	NULL
Two	NULL
Separate	NULL
RANK	NULL
Cytoplasmic	NULL
Domains-The	NULL
interaction	NULL
of	NULL
TRAFs	NULL
with	NULL
multiple	NULL
RANK	NULL
cytoplasmic	NULL
domains	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
some	NULL
TRAF	NULL
's	NULL
to	NULL
mediate	NULL
NF-B	NULL
activation	NULL
(	NULL
7	NULL
,	NULL
24	NULL
)	NULL
suggests	NULL
that	NULL
the	NULL
deletion	NULL
of	NULL
TBS	NULL
may	NULL
abrogate	NULL
NF-	NULL
«	NULL
B-dependent	NULL
signaling	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
COOH-terminal	NULL
cytoplasmic	NULL
deletions	NULL
of	NULL
RANK	NULL
were	NULL
expressed	NULL
in	NULL
293	NULL
cells	NULL
and	NULL
reporter	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Equivalent	NULL
expression	NULL
levels	NULL
of	NULL
each	NULL
RANK	NULL
construct	NULL
were	NULL
confirmed	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
metabolically	NULL
labeled	NULL
proteins	NULL
and	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
the	NULL
RANK	NULL
deletion	NULL
construct	NULL
lacking	NULL
the	NULL
COOH-terminal	NULL
72	NULL
amino	NULL
acids	NULL
(	NULL
RANK	NULL
A544	NULL
)	NULL
resulted	NULL
in	NULL
reduced	NULL
NF-	NULL
«	NULL
B	NULL
reporter	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RANKL	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
RANKL	NULL
treatment	NULL
of	NULL
RANK	NULL
A544-expressing	NULL
cells	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
full-length	NULL
RANK	NULL
.	NULL

Further	NULL
deletion	NULL
of	NULL
COOH-terminal	NULL
sequences	NULL
had	NULL
minimal	NULL
effects	NULL
on	NULL
the	NULL
constitutive	NULL
and	NULL
RANKL-mediated	NULL
reporter	NULL
activity	NULL
until	NULL
the	NULL
removal	NULL
of	NULL
amino	NULL
acids	NULL
339-422	NULL
(	NULL
construct	NULL
RANK	NULL
A339	NULL
)	NULL
,	NULL
which	NULL
completely	NULL
abrogated	NULL
both	NULL
constitutive	NULL
signaling	NULL
and	NULL
responsiveness	NULL
to	NULL
RANKL	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
RANK	NULL
cytoplasmic	NULL
determinants	NULL
had	NULL
similar	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
as	NULL
determined	NULL
by	NULL
direct	NULL
EMSA	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
RANK	NULL
contains	NULL
two	NULL
domains	NULL
(	NULL
amino	NULL
acids	NULL
339-422	NULL
and	NULL
544-616	NULL
)	NULL
within	NULL
its	NULL
cytoplasmic	NULL
tail	NULL
important	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
.	NULL

These	NULL
two	NULL
RANK	NULL
functional	NULL
regions	NULL
correspond	NULL
with	NULL
the	NULL
two	NULL
domains	NULL
that	NULL
affect	NULL
binding	NULL
of	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
(	NULL
amino	NULL
acids	NULL
544-616	NULL
)	NULL
and	NULL
TRAF6	NULL
(	NULL
amino	NULL
acids	NULL
339-422	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
deletional	NULL
analysis	NULL
of	NULL
RANK	NULL
domains	NULL
important	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
expose	NULL
differences	NULL
between	NULL
RANK	NULL
signal	NULL
transduc-tion	NULL
as	NULL
a	NULL
result	NULL
of	NULL
receptor	NULL
overexpression	NULL
and	NULL
RANKL	NULL
treatment	NULL
.	NULL

Constitutive	NULL
signaling	NULL
resulting	NULL
from	NULL
RANK	NULL
overexpression	NULL
was	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
COOH-terminal	NULL
72	NULL
amino	NULL
acids	NULL
(	NULL
RANK	NULL
A544	NULL
)	NULL
.	NULL

However	NULL
,	NULL
RANKL-mediated	NULL
signaling	NULL
was	NULL
only	NULL
affected	NULL
by	NULL
the	NULL
deletion	NULL
of	NULL
amino	NULL
acids	NULL
339-422	NULL
correlating	NULL
to	NULL
the	NULL
loss	NULL
of	NULL
direct	NULL
TRAF6G	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
RANK/RANKL	NULL
Is	NULL
Mediated	NULL
by	NULL
TRAFs-In	NULL
the	NULL
absence	NULL
of	NULL
receptor	NULL
expression	NULL
,	NULL
TRAF	NULL
's	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
as	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
(	NULL
7	NULL
,	NULL
24	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
functional	NULL
involvement	NULL
of	NULL
these	NULL
TRAFs	NULL
in	NULL
RANK-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
293	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
RANK	NULL
and	NULL
expression	NULL
vectors	NULL
encoding	NULL
truncations	NULL
of	NULL
TRAF2	NULL
,	NULL
TRAF5	NULL
,	NULL
and	NULL
TRAF6	NULL
,	NULL
each	NULL
of	NULL
which	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
suppress	NULL
NF-kB	NULL
signaling	NULL
in	NULL
a	NULL
dominant	NULL
negative	NULL
manner	NULL
(	NULL
7	NULL
,	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Co-expression	NULL
of	NULL
the	NULL
zinc	NULL
ring-deleted	NULL
forms	NULL
of	NULL
TRAFs	NULL
2	NULL
,	NULL
5	NULL
,	NULL
or	NULL
6	NULL
each	NULL
inhibited	NULL
the	NULL
RANKL-inducible	NULL
reporter	NULL
activity	NULL
in	NULL
a	NULL
concentration-depend-ent	NULL
fashion	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
only	NULL
NH-truncated	NULL
TRAF2	NULL
and	NULL
TRAF5	NULL
suppressed	NULL
constitutive	NULL
signaling	NULL
from	NULL
the	NULL
full-length	NULL
RANK	NULL
.	NULL

The	NULL
TRAF6	NULL
selectively	NULL
inhibited	NULL
RANKL-induced	NULL
signaling	NULL
,	NULL
but	NULL
not	NULL
constitutive	NULL
signaling	NULL
,	NULL
revealing	NULL
a	NULL
specific	NULL
role	NULL
for	NULL
TRAF6	NULL
in	NULL
RANKL-induced	NULL
signaling	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
by	NULL
RANK-To	NULL
determine	NULL
whether	NULL
human	NULL
RANK	NULL
receptor	NULL
will	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
JNK	NULL
,	NULL
protein	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
293	NULL
cells	NULL
overexpressing	NULL
RANK	NULL
.	NULL

Transfection	NULL
of	NULL
RANK	NULL
significantly	NULL
induced	NULL
JNK	NULL
activity	NULL
to	NULL
levels	NULL
exceeding	NULL
that	NULL
seen	NULL
with	NULL
TNFa	NULL
treatment	NULL
or	NULL
overexpression	NULL
of	NULL
p60	NULL
TNFR	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Truncation	NULL
of	NULL
the	NULL
COOH-terminal	NULL
72	NULL
amino	NULL
acids	NULL
of	NULL
RANK	NULL
abrogated	NULL
the	NULL
majority	NULL
of	NULL
JNK	NULL
activity	NULL
.	NULL

The	NULL
residual	NULL
JNK	NULL
activity	NULL
was	NULL
completely	NULL
inhibited	NULL
after	NULL
the	NULL
truncation	NULL
of	NULL
amino	NULL
acids	NULL
339-422	NULL
in	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
RANK	NULL
A339	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
two	NULL
distinct	NULL
RANK	NULL
cytoplasmic	NULL
domains	NULL
(	NULL
residues	NULL
544-616	NULL
and	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
A	NULL
£03	NULL
Dmm	NULL
P	NULL
marra	NULL
40	NULL
4	NULL
T	NULL
2	NULL
7	NULL
0	NULL
a	NULL
B	NULL
3	NULL
0	NULL
F	NULL
tt	NULL
2	NULL
2	NULL
**	NULL
}	NULL
0	NULL
ind	NULL
®	NULL
Fo	NULL
£	NULL
$	NULL
0	NULL
104	NULL
'	NULL
o	NULL
3	NULL
-	NULL
L	NULL
0	NULL
+_-__-+	NULL
£._____4	NULL
£._._-4	NULL
p	NULL
...	NULL
i_	NULL
}	NULL
6	NULL
A	NULL
®	NULL
&	NULL
xi	NULL
?	NULL

‘	NULL
if	NULL
}	NULL
?	NULL

&	NULL
``	NULL
i	NULL
a*	NULL
``	NULL
&	NULL
€	NULL
F	NULL
$	NULL
Jo	NULL
Jo	NULL
,	NULL
C	NULL
<	NULL
<	NULL
his	NULL
<	NULL
3°	NULL
B	NULL
DNA	NULL
TRANSFECTED	NULL
_o	NULL
20	NULL
R0	NULL
0	NULL
WT	NULL
MUT	NULL
2	NULL
2	NULL
~	NULL
E	NULL
UNLABELED	NULL
COMPETITOR	NULL
OLIGOS	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
COOH-terminal	NULL
deletions	NULL
of	NULL
RANK	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
.	NULL

A	NULL
,	NULL
luciferase	NULL
analysis	NULL
of	NULL
lysates	NULL
prepared	NULL
from	NULL
298	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
RANK	NULL
construct	NULL
.	NULL

Reporter	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
recombinant	NULL
human	NULL
RANKL-leucine	NULL
zipper	NULL
(	NULL
rhRANKL	NULL
)	NULL
at	NULL
500	NULL
ng/ml	NULL
for	NULL
18	NULL
h.	NULL
The	NULL
bottom	NULL
panel	NULL
summarizes	NULL
the	NULL
in	NULL
vitro	NULL
TRAF	NULL
binding	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
various	NULL
RANK	NULL
constructs	NULL
.	NULL

Nuclear	NULL
lysates	NULL
were	NULL
prepared	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
DNA/protein	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

The	NULL
empty	NULL
vector	NULL
(	NULL
pDC304	NULL
)	NULL
did	NULL
not	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

As	NULL
positive	NULL
controls	NULL
,	NULL
either	NULL
mock-transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TNFa	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
20	NULL
min	NULL
or	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
p60	NULL
TNFR	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
reaction	NULL
was	NULL
confirmed	NULL
by	NULL
competition	NULL
with	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
non-labeled	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
mutated	NULL
NF-kB	NULL
binding	NULL
site	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
.	NULL

339-422	NULL
)	NULL
play	NULL
functional	NULL
roles	NULL
in	NULL
JNK	NULL
activation	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
domains	NULL
necessary	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
described	NULL
above	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Essential	NULL
Role	NULL
of	NULL
the	NULL
TRAFG6	NULL
Binding	NULL
Site	NULL
in	NULL
NF-kB	NULL
,	NULL
but	NULL
Not	NULL
JNK	NULL
,	NULL
Signaling	NULL
by	NULL
RANK-The	NULL
experiments	NULL
utilizing	NULL
overexpression	NULL
of	NULL
COOH-terminal	NULL
RANK	NULL
truncation	NULL
mutants	NULL
demonstrate	NULL
that	NULL
TBS	NULL
II	NULL
and	NULL
III	NULL
contribute	NULL
to	NULL
JNK	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
these	NULL
RANK	NULL
mutants	NULL
with	NULL
exogenously	NULL
added	NULL
RANKL	NULL
revealed	NULL
that	NULL
the	NULL
region	NULL
which	NULL
binds	NULL
TRAF6	NULL
in	NULL
vitro	NULL
(	NULL
residues	NULL
340-421	NULL
)	NULL
plays	NULL
the	NULL
most	NULL
critical	NULL
role	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

To	NULL
test	NULL
the	NULL
role	NULL
of	NULL
this	NULL
domain	NULL
directly	NULL
,	NULL
we	NULL
constructed	NULL
an	NULL
in-frame	NULL
deletion	NULL
(	NULL
RANK	NULL
A340-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
E	NULL
]	NULL
RANK	NULL
I	NULL
manceonnanke	NULL
50	NULL
Luciferase	NULL
activity	NULL
{	NULL
fold	NULL
induction	NULL
)	NULL
DN-TRAF	NULL
cDNA	NULL
so	NULL
-	NULL
250	NULL
so	NULL
_	NULL
250	NULL
so	NULL
_	NULL
250	NULL
(	NULL
{	NULL
ng/well	NULL
)	NULL
DN-TRAF2	NULL
DN-TRAFS	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Involvement	NULL
of	NULL
TRAF2	NULL
,	NULL
TRAF5	NULL
,	NULL
and	NULL
TRAF6	NULL
in	NULL
RANKL-and	NULL
overexpression-induced	NULL
NF-B	NULL
activation	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
the	NULL
full-length	NULL
RANK	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B-responsive	NULL
IL-8	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
indicated	NULL
dominant	NULL
negative	NULL
TRAF2	NULL
,	NULL
TRAF5	NULL
,	NULL
or	NULL
TRAFG	NULL
constructs	NULL
were	NULL
also	NULL
co-transfected	NULL
in	NULL
increasing	NULL
concentrations	NULL
(	NULL
50-250	NULL
ng/transfection	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
DNA	NULL
were	NULL
equalized	NULL
for	NULL
each	NULL
transfection	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
empty	NULL
vector	NULL
pDC304	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
500	NULL
ng/ml	NULL
recombinant	NULL
human	NULL
RANKL-leucine	NULL
zipper	NULL
(	NULL
rhRANKL	NULL
)	NULL
where	NULL
indicated	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
16-18	NULL
h	NULL
after	NULL
treatment	NULL
.	NULL

As	NULL
a	NULL
specificity	NULL
control	NULL
for	NULL
the	NULL
dominant	NULL
negative	NULL
activity	NULL
of	NULL
the	NULL
TRAF	NULL
's	NULL
,	NULL
transfection	NULL
of	NULL
cells	NULL
with	NULL
up	NULL
to	NULL
250	NULL
ng	NULL
of	NULL
pDC304/LACZ	NULL
did	NULL
not	NULL
affect	NULL
RANK-	NULL
or	NULL
RANKL-dependent	NULL
signaling	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Relative	NULL
luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
to	NULL
-galactosidase	NULL
expression	NULL
levels	NULL
and	NULL
are	NULL
reported	NULL
as	NULL
mean	NULL
values	NULL
+	NULL
S.E	NULL
.	NULL

from	NULL
triplicate	NULL
transfections	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

DN-TRAF6	NULL
DNA	NULL
TRANSFECTED	NULL
|	NULL
I	NULL
,	NULL
#	NULL
.	NULL

@	NULL
m	NULL
0	NULL
§	NULL
{	NULL
§4¢	NULL
¢	NULL
$	NULL
S	NULL
§	NULL
S5	NULL
$	NULL
-	NULL
_-	NULL
ZS	NULL
ZC	NULL
C	NULL
€	NULL
$	NULL
8	NULL
_-	NULL
97	NULL
-	NULL
69	NULL
-	NULL
46	NULL
Fe	NULL
U	NULL
-	NULL
~-	NULL
cam	NULL
phosphorylated	NULL
``	NULL
GST-c-jun	NULL
(	NULL
1-169	NULL
)	NULL
-39	NULL
(	NULL
-	NULL
22	NULL
(	NULL
kDa	NULL
)	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
by	NULL
RANK	NULL
.	NULL

298	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
(	NULL
pDC304	NULL
)	NULL
control	NULL
,	NULL
p60	NULL
TNFR	NULL
expression	NULL
construct	NULL
,	NULL
full-length	NULL
RANK	NULL
,	NULL
or	NULL
the	NULL
indicated	NULL
COOH-terminal	NULL
RANK	NULL
deletion	NULL
expression	NULL
vectors	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TNF-	NULL
@	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
20	NULL
min	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunopre-cipitated	NULL
with	NULL
anti-JNK	NULL
antibodies	NULL
and	NULL
the	NULL
JNK	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
an	NULL
immune-complex	NULL
kinase	NULL
assay	NULL
using	NULL
GST-c-Jun-	NULL
(	NULL
1-169	NULL
)	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

The	NULL
products	NULL
of	NULL
the	NULL
kinase	NULL
assay	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
position	NULL
of	NULL
phosphorylated	NULL
GST-c-Jun	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

421	NULL
)	NULL
,	NULL
which	NULL
removes	NULL
the	NULL
TRAF6G	NULL
binding	NULL
site	NULL
and	NULL
leaves	NULL
intact	NULL
the	NULL
downstream	NULL
domains	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
TRAF	NULL
's	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
(	NULL
TBS	NULL
II	NULL
and	NULL
III	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
resulting	NULL
from	NULL
either	NULL
overexpression	NULL
or	NULL
RANKL	NULL
activation	NULL
of	NULL
RANK	NULL
A340-421	NULL
as	NULL
compared	NULL
with	NULL
full-length	NULL
RANK	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
response	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
RANK	NULL
A339	NULL
mutant	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
incapable	NULL
of	NULL
binding	NULL
any	NULL
TRAF	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
result	NULL
confirms	NULL
the	NULL
critical	NULL
requirement	NULL
for	NULL
TRAF6	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
illustrates	NULL
that	NULL
the	NULL
downstream	NULL
TBS	NULL
II	NULL
and	NULL
III	NULL
can	NULL
not	NULL
function	NULL
independently	NULL
to	NULL
mediate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Deletion	NULL
of	NULL
RANK	NULL
residues	NULL
340-421	NULL
reduced	NULL
JNK	NULL
activity	NULL
relative	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
full-length	NULL
RANK	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
;	NULL
34125	NULL
A	NULL
r=	NULL
[	NULL
_	NULL
]	NULL
Medium	NULL
ff	NULL
rhRANKL	NULL
0	NULL
20	NULL
28	NULL
is	NULL
>	NULL
0	NULL
5	NULL
3	NULL
16	NULL
0T	NULL
14	NULL
©	NULL
2	NULL
an	NULL
|	NULL
mZ	NULL
10	NULL
©	NULL
oO	NULL
;	NULL
hs	NULL
Yom	NULL
&	NULL
o	NULL
6	NULL
``	NULL
O2	NULL
4	NULL
z	NULL
“	NULL
34	NULL
2	NULL
o	NULL
-	NULL
o	NULL
_	NULL
Vector	NULL
-	NULL
FL	NULL
_	NULL
RANK	NULL
RANK	NULL
RANK	NULL
RANK	NULL
A421	NULL
A339	NULL
A340-421	NULL
P	NULL
&	NULL
aad	NULL
G	NULL
g	NULL
€	NULL
ao	NULL
&	NULL
&	NULL
§	NULL
¢	NULL
$	NULL
eZ	NULL
k	NULL
&	NULL
if	NULL
?	NULL

“	NULL
k	NULL
?	NULL

4.57	NULL
*	NULL
.J	NULL
.	NULL

PRansrectep	NULL
:	NULL
$	NULL
$	NULL
§	NULL
vet	NULL
ve-	NULL
é	NULL
.	NULL

@	NULL
@	NULL
C	NULL
C	NULL
&	NULL
-	NULL
«	NULL
wane	NULL
Wh	NULL
<	NULL
--	NULL
-anl	NULL
phosphorylated	NULL
GST	NULL
c-Jun	NULL
(	NULL
1-169	NULL
)	NULL
DNA	NULL
TRANSFECTED	NULL
:	NULL
99	NULL
.	NULL

&	NULL
o	NULL
T	NULL
``	NULL
phosphorylated	NULL
GST	NULL
c-Jun	NULL
(	NULL
1-169	NULL
)	NULL
soluble	NULL
RANKL	NULL
treatment	NULL
:	NULL
po	NULL
®	NULL
$	NULL
®	NULL
+	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

An	NULL
internal	NULL
deletion	NULL
of	NULL
the	NULL
TRAFG	NULL
binding	NULL
site	NULL
completely	NULL
inhibits	NULL
RANK-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
but	NULL
only	NULL
partially	NULL
inhibits	NULL
JNK	NULL
activation	NULL
.	NULL

A	NULL
,	NULL
human	NULL
298	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
expression	NULL
vector	NULL
DNA	NULL
and	NULL
relative	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
and	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
RANK	NULL
A840/421	NULL
mutation	NULL
is	NULL
an	NULL
internal	NULL
in-frame	NULL
deletion	NULL
of	NULL
residues	NULL
340-420	NULL
including	NULL
the	NULL
TRAFG	NULL
binding	NULL
site	NULL
.	NULL

B	NULL
,	NULL
human	NULL
298	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
and	NULL
JNK	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

C	NULL
,	NULL
to	NULL
examine	NULL
RANKL-induced	NULL
JNK	NULL
activation	NULL
,	NULL
298	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
each	NULL
expression	NULL
vector	NULL
and	NULL
JNK	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
GST-c-Jun-	NULL
(	NULL
1-169	NULL
)	NULL
as	NULL
a	NULL
substrate	NULL
24	NULL
h	NULL
later	NULL
.	NULL

This	NULL
concentration	NULL
of	NULL
full-length	NULL
RANK	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
activate	NULL
JNK	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
added	NULL
RANKL	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
ug/ml	NULL
soluble	NULL
rhRANKL	NULL
for	NULL
20	NULL
min	NULL
prior	NULL
to	NULL
cell	NULL
lysis	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
immunoprecipitation	NULL
of	NULL
*°S-labeled	NULL
RANK	NULL
demonstrated	NULL
equivalent	NULL
expression	NULL
of	NULL
each	NULL
protein	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

however	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
results	NULL
,	NULL
this	NULL
internal	NULL
deletion	NULL
still	NULL
retained	NULL
some	NULL
activation	NULL
of	NULL
JNK	NULL
above	NULL
the	NULL
vector	NULL
control	NULL
.	NULL

This	NULL
reduced	NULL
,	NULL
yet	NULL
detectable	NULL
,	NULL
JNK	NULL
activity	NULL
was	NULL
also	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
34126	NULL
exhibited	NULL
after	NULL
RANKL	NULL
activation	NULL
of	NULL
the	NULL
RANK	NULL
A340-421	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
region	NULL
(	NULL
340-421	NULL
)	NULL
,	NULL
which	NULL
we	NULL
have	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
binding	NULL
TRAF6	NULL
directly	NULL
,	NULL
is	NULL
required	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
contributes	NULL
to	NULL
JNK	NULL
activation	NULL
by	NULL
RANK	NULL
.	NULL

DISCUSSION	NULL
The	NULL
TNFR	NULL
superfamily	NULL
consists	NULL
of	NULL
type	NULL
I	NULL
membrane	NULL
proteins	NULL
that	NULL
can	NULL
mediate	NULL
diverse	NULL
effects	NULL
including	NULL
apoptosis	NULL
,	NULL
differen-tiation	NULL
,	NULL
and	NULL
survival	NULL
upon	NULL
ligand-mediated	NULL
receptor	NULL
activation	NULL
.	NULL

To	NULL
date	NULL
,	NULL
each	NULL
TNFR	NULL
family	NULL
member	NULL
without	NULL
a	NULL
death	NULL
domain	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
cytoplasmic	NULL
TRAF	NULL
adaptor	NULL
proteins	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
.	NULL

However	NULL
,	NULL
signaling	NULL
pathways	NULL
affected	NULL
by	NULL
different	NULL
TNFR	NULL
members	NULL
are	NULL
unique	NULL
and	NULL
frequently	NULL
non-redundant	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
RANK	NULL
signaling	NULL
through	NULL
TRAF	NULL
's	NULL
may	NULL
then	NULL
be	NULL
determined	NULL
by	NULL
multiple	NULL
factors	NULL
:	NULL
1	NULL
)	NULL
the	NULL
cellular	NULL
abundance	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
TRAF	NULL
proteins	NULL
;	NULL
2	NULL
)	NULL
the	NULL
relative	NULL
affinity	NULL
of	NULL
TRAFs	NULL
for	NULL
cytoplasmic	NULL
TRAF-binding	NULL
proteins	NULL
including	NULL
other	NULL
TRAF	NULL
's	NULL
,	NULL
I-TRAF/TANK	NULL
,	NULL
TRIP	NULL
,	NULL
C-IAPs	NULL
,	NULL
and	NULL
A20	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

6	NULL
)	NULL
;	NULL
and	NULL
3	NULL
)	NULL
the	NULL
relative	NULL
affinity	NULL
of	NULL
these	NULL
adaptor/effector	NULL
proteins	NULL
for	NULL
the	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
five	NULL
of	NULL
the	NULL
six	NULL
known	NULL
TRAF	NULL
can	NULL
directly	NULL
bind	NULL
RANK	NULL
cytoplasmic	NULL
determinants	NULL
,	NULL
constituting	NULL
the	NULL
largest	NULL
complement	NULL
of	NULL
TRAF	NULL
proteins	NULL
known	NULL
to	NULL
bind	NULL
any	NULL
TNFR	NULL
family	NULL
member	NULL
and	NULL
suggesting	NULL
that	NULL
RANK	NULL
may	NULL
utilize	NULL
a	NULL
versatile	NULL
cast	NULL
of	NULL
effector	NULL
molecules	NULL
to	NULL
transmit	NULL
signals	NULL
.	NULL

RANK	NULL
contains	NULL
two	NULL
independent	NULL
TRAF	NULL
binding	NULL
regions	NULL
:	NULL
amino	NULL
acids	NULL
544-616	NULL
,	NULL
which	NULL
affects	NULL
binding	NULL
of	NULL
multiple	NULL
TRAFs	NULL
(	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
;	NULL
and	NULL
340-421	NULL
,	NULL
which	NULL
binds	NULL
TRAF6	NULL
only	NULL
.	NULL

We	NULL
engineered	NULL
specific	NULL
point	NULL
mutants	NULL
of	NULL
the	NULL
putative	NULL
RANK	NULL
TBS	NULL
in	NULL
order	NULL
to	NULL
reveal	NULL
critical	NULL
RANK	NULL
features	NULL
for	NULL
TRAF	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

Alanine	NULL
substitutions	NULL
within	NULL
positions	NULL
571-573	NULL
uncovered	NULL
selective	NULL
binding	NULL
determinants	NULL
for	NULL
TRAF3	NULL
at	NULL
this	NULL
site	NULL
.	NULL

Point	NULL
mutations	NULL
at	NULL
positions	NULL
609-610	NULL
significantly	NULL
affected	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
5	NULL
binding	NULL
to	NULL
RANK	NULL
without	NULL
affecting	NULL
TRAF3	NULL
or	NULL
TRAF6	NULL
binding	NULL
.	NULL

The	NULL
critical	NULL
Q-E	NULL
element	NULL
of	NULL
these	NULL
two	NULL
TBS	NULL
in	NULL
RANK	NULL
is	NULL
similar	NULL
to	NULL
TRAF	NULL
binding	NULL
elements	NULL
found	NULL
in	NULL
CD30	NULL
(	NULL
22	NULL
)	NULL
and	NULL
OX40	NULL
(	NULL
12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
receptor-specific	NULL
selectivity	NULL
and	NULL
affinity	NULL
of	NULL
TRAF	NULL
binding	NULL
appears	NULL
to	NULL
be	NULL
influenced	NULL
by	NULL
sequences	NULL
surrounding	NULL
this	NULL
core	NULL
region	NULL
.	NULL

Deletion	NULL
analysis	NULL
clearly	NULL
shows	NULL
that	NULL
TRAF6	NULL
directly	NULL
binds	NULL
to	NULL
RANK	NULL
within	NULL
amino	NULL
acids	NULL
340-421	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
amino	NULL
acids	NULL
544-616	NULL
resulted	NULL
in	NULL
a	NULL
50	NULL
%	NULL
loss	NULL
of	NULL
TRAF6G	NULL
binding	NULL
inten-sity	NULL
,	NULL
but	NULL
direct	NULL
binding	NULL
of	NULL
TRAF6	NULL
to	NULL
this	NULL
latter	NULL
region	NULL
of	NULL
RANK	NULL
was	NULL
not	NULL
unambiguously	NULL
determined	NULL
.	NULL

Since	NULL
alanine	NULL
substitutions	NULL
of	NULL
TBS	NULL
within	NULL
this	NULL
COOH-terminal	NULL
72	NULL
amino	NULL
acids	NULL
did	NULL
not	NULL
reduce	NULL
TRAF6	NULL
binding	NULL
,	NULL
either	NULL
TRAF6	NULL
binds	NULL
to	NULL
two	NULL
disparate	NULL
sites	NULL
(	NULL
within	NULL
positions	NULL
340-421	NULL
and	NULL
544-616	NULL
)	NULL
independently	NULL
of	NULL
other	NULL
TRAF	NULL
proteins	NULL
or	NULL
some	NULL
structure	NULL
within	NULL
the	NULL
COOH-terminal	NULL
tail	NULL
can	NULL
positively	NULL
affect	NULL
TRAFG	NULL
binding	NULL
to	NULL
the	NULL
upstream	NULL
(	NULL
840-421	NULL
)	NULL
region	NULL
.	NULL

Current	NULL
experiments	NULL
are	NULL
under	NULL
way	NULL
to	NULL
distinguish	NULL
these	NULL
possibilities	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
RANK	NULL
triggering	NULL
of	NULL
both	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
JNK	NULL
pathways	NULL
requires	NULL
cytoplasmic	NULL
elements	NULL
necessary	NULL
for	NULL
TRAF	NULL
binding	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
the	NULL
COOH-terminal	NULL
72	NULL
residues	NULL
(	NULL
RANK	NULL
A544	NULL
)	NULL
,	NULL
which	NULL
decreases	NULL
binding	NULL
of	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
major	NULL
reduction	NULL
of	NULL
RANK	NULL
overexpression-induced	NULL
NF-kB	NULL
and	NULL
JNK	NULL
activity	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Any	NULL
residual	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
JNK	NULL
activity	NULL
was	NULL
eliminated	NULL
when	NULL
the	NULL
TRAF6	NULL
binding	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
340-421	NULL
)	NULL
was	NULL
removed	NULL
.	NULL

RANKL	NULL
treatment	NULL
of	NULL
RANK	NULL
A544-expressing	NULL
cells	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
to	NULL
levels	NULL
equivalent	NULL
to	NULL
full-length	NULL
RANK	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
ability	NULL
to	NULL
directly	NULL
bind	NULL
TRAF6	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
direct	NULL
binding	NULL
of	NULL
other	NULL
TRAF	NULL
's	NULL
,	NULL
allows	NULL
optimal	NULL
RANK	NULL
signaling	NULL
.	NULL

Although	NULL
we	NULL
identified	NULL
a	NULL
region	NULL
with	NULL
limited	NULL
homology	NULL
to	NULL
other	NULL
TBS	NULL
at	NULL
residues	NULL
353-357	NULL
(	NULL
site	NULL
I	NULL
;	NULL
P-S-Q-P-T	NULL
)	NULL
within	NULL
the	NULL
upstream	NULL
region	NULL
important	NULL
for	NULL
RANK	NULL
signal	NULL
transduction	NULL
,	NULL
we	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
were	NULL
unable	NULL
to	NULL
identify	NULL
the	NULL
specific	NULL
binding	NULL
site	NULL
for	NULL
TRAF6G	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
directly	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
TRAFG	NULL
binding	NULL
is	NULL
pivotal	NULL
for	NULL
RANK-mediated	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
JNK	NULL
activation	NULL
,	NULL
we	NULL
constructed	NULL
an	NULL
in-frame	NULL
deletion	NULL
of	NULL
amino	NULL
acids	NULL
340-421	NULL
(	NULL
RANK	NULL
A340-421	NULL
)	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
resulted	NULL
in	NULL
complete	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
while	NULL
JNK	NULL
activation	NULL
was	NULL
inhibited	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
separate	NULL
regions	NULL
of	NULL
RANK	NULL
(	NULL
340-421	NULL
and	NULL
544-616	NULL
)	NULL
can	NULL
independently	NULL
activate	NULL
JNK	NULL
by	NULL
virtue	NULL
of	NULL
the	NULL
appropriate	NULL
TRAF	NULL
binding	NULL
to	NULL
each	NULL
of	NULL
these	NULL
domains	NULL
.	NULL

These	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
for	NULL
activation	NULL
of	NULL
JNK	NULL
,	NULL
TRAF6	NULL
is	NULL
functionally	NULL
redundant	NULL
with	NULL
other	NULL
TRAFs	NULL
(	NULL
TRAF2	NULL
and	NULL
TRAF5	NULL
)	NULL
binding	NULL
downstream	NULL
.	NULL

Since	NULL
residues	NULL
340-421	NULL
are	NULL
necessary	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
by	NULL
RANK	NULL
in	NULL
this	NULL
model	NULL
cell	NULL
system	NULL
,	NULL
TRAFG	NULL
binding	NULL
and	NULL
coupling	NULL
to	NULL
the	NULL
appropriate	NULL
downstream	NULL
effector	NULL
proteins	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
this	NULL
pathway	NULL
.	NULL

Similar	NULL
to	NULL
TRAF2	NULL
and	NULL
TRAF5	NULL
,	NULL
TRAF6	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
upstream	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
JNK	NULL
pathways	NULL
(	NULL
24	NULL
)	NULL
;	NULL
however	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
,	NULL
after	NULL
RANK	NULL
activation	NULL
,	NULL
TRAF6	NULL
may	NULL
couple	NULL
to	NULL
distinct	NULL
downstream	NULL
effector	NULL
proteins	NULL
from	NULL
those	NULL
activated	NULL
by	NULL
TRAF2	NULL
or	NULL
TRAFS5	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
TRAF6	NULL
to	NULL
functionally	NULL
complement	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
in	NULL
RANK	NULL
is	NULL
reminiscent	NULL
of	NULL
its	NULL
role	NULL
in	NULL
CD40	NULL
signaling	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
RANK	NULL
,	NULL
CD40	NULL
binds	NULL
TRAF6	NULL
via	NULL
a	NULL
distinct	NULL
domain	NULL
independently	NULL
of	NULL
other	NULL
TRAF	NULL
interactions	NULL
and	NULL
can	NULL
mediate	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
direct	NULL
TRAF2	NULL
or	NULL
TRAFS5	NULL
binding	NULL
.	NULL

The	NULL
NH	NULL
,	NULL
-terminal	NULL
deletion	NULL
of	NULL
TRAFG	NULL
only	NULL
affects	NULL
RANKL-induced	NULL
reporter	NULL
activity	NULL
,	NULL
while	NULL
the	NULL
deletions	NULL
of	NULL
TRAFs	NULL
2	NULL
and	NULL
5	NULL
affected	NULL
signals	NULL
resulting	NULL
from	NULL
both	NULL
RANKL	NULL
treatment	NULL
and	NULL
RANK	NULL
overexpression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
illustrates	NULL
another	NULL
unique	NULL
feature	NULL
of	NULL
TRAF6	NULL
in	NULL
RANK	NULL
signaling	NULL
,	NULL
and	NULL
also	NULL
suggests	NULL
that	NULL
there	NULL
may	NULL
be	NULL
qualitative	NULL
differences	NULL
in	NULL
TNFR	NULL
family	NULL
signaling	NULL
resulting	NULL
from	NULL
the	NULL
normal	NULL
interaction	NULL
of	NULL
ligand	NULL
and	NULL
receptor	NULL
versus	NULL
the	NULL
artificial	NULL
signal	NULL
emanating	NULL
from	NULL
overexpressed	NULL
receptor	NULL
.	NULL

This	NULL
latter	NULL
observation	NULL
has	NULL
implications	NULL
for	NULL
the	NULL
signaling	NULL
mechanisms	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
,	NULL
which	NULL
mimics	NULL
a	NULL
con-stitutively	NULL
active	NULL
receptor	NULL
by	NULL
aggregating	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
25	NULL
)	NULL
and	NULL
utilizes	NULL
TRAF	NULL
proteins	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
26-29	NULL
)	NULL
and	NULL
other	NULL
pathways	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
RANK	NULL
may	NULL
utilize	NULL
TRAF-independent	NULL
signaling	NULL
mechanisms	NULL
during	NULL
activation	NULL
or	NULL
differentiation	NULL
of	NULL
RANK-expressing	NULL
cells	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
the	NULL
functional	NULL
consequence	NULL
of	NULL
TRAF	NULL
binding	NULL
to	NULL
RANK	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
downstream	NULL
regulation	NULL
of	NULL
multiple	NULL
gene	NULL
activation	NULL
path-ways	NULL
.	NULL

The	NULL
resulting	NULL
activation	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
play	NULL
an	NULL
unequivocal	NULL
role	NULL
to	NULL
trigger	NULL
inflamma-tory	NULL
,	NULL
immune	NULL
,	NULL
and	NULL
acute	NULL
phase	NULL
gene	NULL
expression	NULL
.	NULL

While	NULL
these	NULL
studies	NULL
expose	NULL
a	NULL
particular	NULL
role	NULL
for	NULL
TRAF6G	NULL
in	NULL
RANK	NULL
signal	NULL
transduction	NULL
,	NULL
the	NULL
exact	NULL
localization	NULL
of	NULL
the	NULL
TRAF6	NULL
binding	NULL
sites	NULL
will	NULL
help	NULL
to	NULL
further	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
TRAF6	NULL
binding	NULL
in	NULL
RANKL-induced	NULL
signaling	NULL
events	NULL
.	NULL

The	NULL
examination	NULL
of	NULL
RANK	NULL
constructs	NULL
incapable	NULL
of	NULL
binding	NULL
each	NULL
of	NULL
the	NULL
different	NULL
TRAF	NULL
's	NULL
in	NULL
the	NULL
context	NULL
of	NULL
cellular	NULL
activation	NULL
(	NULL
e.g	NULL
.	NULL

DC	NULL
)	NULL
or	NULL
differentiation	NULL
will	NULL
be	NULL
important	NULL
to	NULL
evaluate	NULL
TRAF-dependent	NULL
and	NULL
independent	NULL
RANK	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Kathy	NULL
Maggiora	NULL
for	NULL
cell	NULL
transfection	NULL
help	NULL
;	NULL
Dirk	NULL
Smith	NULL
for	NULL
the	NULL
pDC304	NULL
TRAF6-	NULL
(	NULL
289-522	NULL
)	NULL
construct	NULL
;	NULL
Jeanette	NULL
Bertles	NULL
,	NULL
Chang-Pin	NULL
Huang	NULL
,	NULL
Marty	NULL
Timour	NULL
and	NULL
Gordana	NULL
Sapina	NULL
for	NULL
DNA	NULL
sequencing	NULL
;	NULL
Drs	NULL
.	NULL

Doug	NULL
Williams	NULL
and	NULL
Timothy	NULL
Bird	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
;	NULL
Mari	NULL
Hall	NULL
and	NULL
Gary	NULL
Carlton	NULL
for	NULL
graphics	NULL
as-sistance	NULL
;	NULL
and	NULL
Anne	NULL
Aumell	NULL
for	NULL
editorial	NULL
assistance	NULL
.	NULL

Addendum-While	NULL
this	NULL
paper	NULL
was	NULL
under	NULL
review	NULL
,	NULL
Darnay	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
81	NULL
)	NULL
also	NULL
described	NULL
the	NULL
association	NULL
of	NULL
RANK	NULL
with	NULL
TRAFs	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
our	NULL
observations	NULL
here	NULL
,	NULL
these	NULL
authors	NULL
did	NULL
not	NULL
detect	NULL
TRAFG	NULL
binding	NULL
to	NULL
RANK	NULL
cytoplamic	NULL
elements	NULL
upstream	NULL
of	NULL
residue	NULL
530	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
use	NULL
of	NULL
RANK	NULL
purified	NULL
from	NULL
trans-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
TRAFs	NULL
Mediate	NULL
RANK	NULL
Signaling	NULL
fected	NULL
cells	NULL
(	NULL
81	NULL
)	NULL
,	NULL
which	NULL
may	NULL
already	NULL
have	NULL
bound	NULL
cytoplasmic	NULL
proteins	NULL
capable	NULL
of	NULL
competing	NULL
with	NULL
exogenously	NULL
added	NULL
TRAFs	NULL
.	NULL

Our	NULL
data	NULL
reported	NULL
in	NULL
the	NULL
current	NULL
study	NULL
,	NULL
using	NULL
bacterially	NULL
expressed	NULL
RANK	NULL
cytoplasmic	NULL
domain	NULL
and	NULL
in	NULL
vitro	NULL
translated	NULL
TRAF	NULL
's	NULL
,	NULL
clearly	NULL
show	NULL
the	NULL
direct	NULL
association	NULL
of	NULL
TRAF6	NULL
with	NULL
RANK	NULL
residues	NULL
340-421	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Darnay	NULL
et	NULL
al	NULL
.	NULL

(	NULL
81	NULL
)	NULL
did	NULL
not	NULL
observe	NULL
a	NULL
role	NULL
for	NULL
residues	NULL
upstream	NULL
of	NULL
RANK	NULL
580	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
while	NULL
we	NULL
demonstrate	NULL
here	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
residues	NULL
340-421	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
receptor	NULL
overexpression	NULL
and	NULL
RANKL-mediated	NULL
activation	NULL
using	NULL
two	NULL
separate	NULL
assay	NULL
sys-tems	NULL
.	NULL

The	NULL
reasons	NULL
for	NULL
this	NULL
discrepancy	NULL
are	NULL
not	NULL
clear	NULL
and	NULL
may	NULL
be	NULL
due	NULL
to	NULL
subtle	NULL
differences	NULL
in	NULL
the	NULL
experimental	NULL
systems	NULL
used	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Anderson	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Maraskovsky	NULL
,	NULL
E.	NULL
,	NULL
Billingsley	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
Dougall	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Tometsko	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Roux	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Teepe	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Dubose	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
&	NULL
Galibert	NULL
,	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
890	NULL
,	NULL
175-179	NULL
2	NULL
.	NULL

Wong	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Rho	NULL
,	NULL
J.	NULL
,	NULL
Arron	NULL
,	NULL
J.	NULL
,	NULL
Robinson	NULL
,	NULL
E.	NULL
,	NULL
Orlinick	NULL
,	NULL
J.	NULL
,	NULL
Chao	NULL
,	NULL
M.	NULL
,	NULL
Kalachikov	NULL
,	NULL
S.	NULL
,	NULL
Cayani	NULL
,	NULL
E.	NULL
,	NULL
Bartlett	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
III	NULL
,	NULL
Frankel	NULL
,	NULL
W.	NULL
N.	NULL
,	NULL
Lee	NULL
,	NULL
S.	NULL
Y	NULL
.	NULL

&	NULL
Choi	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
25190-25194	NULL
3	NULL
.	NULL

Yasuda	NULL
,	NULL
H.	NULL
,	NULL
Shima	NULL
,	NULL
N.	NULL
,	NULL
Nakagawa	NULL
,	NULL
N.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
K.	NULL
,	NULL
Kinosaki	NULL
,	NULL
M.	NULL
,	NULL
Mochizuki	NULL
,	NULL
S.	NULL
,	NULL
Tomoyasu	NULL
,	NULL
A.	NULL
,	NULL
Yano	NULL
,	NULL
K.	NULL
,	NULL
Goto	NULL
,	NULL
M.	NULL
,	NULL
Murakami	NULL
,	NULL
A.	NULL
,	NULL
Tsuda	NULL
,	NULL
E.	NULL
,	NULL
Morinaga	NULL
,	NULL
T.	NULL
,	NULL
Higashio	NULL
,	NULL
K.	NULL
,	NULL
Udagawa	NULL
,	NULL
N.	NULL
,	NULL
Takahashi	NULL
,	NULL
N.	NULL
&	NULL
Suda	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
3597-3602	NULL
4	NULL
.	NULL

Lacey	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Timms	NULL
,	NULL
E.	NULL
,	NULL
Tan	NULL
,	NULL
H.-L.	NULL
,	NULL
Kelley	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Dunstan	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Burgess	NULL
,	NULL
T.	NULL
,	NULL
Elliott	NULL
,	NULL
R.	NULL
,	NULL
Colombero	NULL
,	NULL
A.	NULL
,	NULL
Elliott	NULL
,	NULL
G.	NULL
,	NULL
Scully	NULL
,	NULL
S.	NULL
,	NULL
Hsu	NULL
,	NULL
H.	NULL
,	NULL
Sullivan	NULL
,	NULL
J.	NULL
,	NULL
Hawkins	NULL
,	NULL
N.	NULL
,	NULL
Davy	NULL
,	NULL
E.	NULL
,	NULL
Capparelli	NULL
,	NULL
C.	NULL
,	NULL
Eli	NULL
,	NULL
A.	NULL
,	NULL
Qian	NULL
,	NULL
Y.-X	NULL
.	NULL

,	NULL
Kaufman	NULL
,	NULL
S.	NULL
,	NULL
Sarosi	NULL
,	NULL
L.	NULL
,	NULL
Shalhoub	NULL
,	NULL
V.	NULL
,	NULL
Senaldi	NULL
,	NULL
G.	NULL
,	NULL
Guo	NULL
,	NULL
J.	NULL
,	NULL
Delaney	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Boyle	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cell	NULL
98	NULL
,	NULL
165-176	NULL
5	NULL
.	NULL

Wong	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Josien	NULL
,	NULL
R.	NULL
,	NULL
Lee	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Sauter	NULL
,	NULL
B.	NULL
,	NULL
Li	NULL
,	NULL
H.-L.	NULL
,	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Choi	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186	NULL
,	NULL
2075-2080	NULL
.	NULL

Darnay	NULL
,	NULL
B.	NULL
G.	NULL
&	NULL
Aggarwal	NULL
,	NULL
B	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Leukocyte	NULL
.	NULL

Biol	NULL
.	NULL

61	NULL
,	NULL
559-566	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
Sarma	NULL
,	NULL
V.	NULL
,	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
&	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
1424-1427	NULL
8	NULL
.	NULL

Ishida	NULL
,	NULL
T.	NULL
,	NULL
Mizushima	NULL
,	NULL
S.	NULL
,	NULL
Azuma	NULL
,	NULL
S.	NULL
,	NULL
Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Tojo	NULL
,	NULL
T.	NULL
,	NULL
Suzuki	NULL
,	NULL
K.	NULL
,	NULL
Aizawa	NULL
,	NULL
S.	NULL
,	NULL
Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
&	NULL
Inoue	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
28745-28748	NULL
9	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
Solovyev	NULL
,	NULL
I.	NULL
,	NULL
Colombero	NULL
,	NULL
A.	NULL
,	NULL
Elliott	NULL
,	NULL
R.	NULL
,	NULL
Kelley	NULL
,	NULL
M.	NULL
&	NULL
Boyle	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
18471-13474	NULL
10	NULL
.	NULL

Marsters	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Ayres	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Skubatch	NULL
,	NULL
M.	NULL
,	NULL
Gray	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
&	NULL
Ashkenazi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
14029-14032	NULL
~	NULL
11	NULL
.	NULL

12	NULL
.	NULL

18	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28.	NULL
.	NULL

Song	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Régnier	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Kirschning	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
&	NULL
Rothe	NULL
,	NULL
M.	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

34127	NULL
Gedrich	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Gilfillan	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Van	NULL
Dongen	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
12852-12858	NULL
Arch	NULL
,	NULL
R.	NULL
H.	NULL
&	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
558-565	NULL
Akiba	NULL
,	NULL
H.	NULL
,	NULL
Nakano	NULL
,	NULL
H.	NULL
,	NULL
Nishinaka	NULL
,	NULL
S.	NULL
,	NULL
Shindo	NULL
,	NULL
M.	NULL
,	NULL
Kobata	NULL
,	NULL
T.	NULL
,	NULL
Atsuta	NULL
,	NULL
M.	NULL
,	NULL
Morimoto	NULL
,	NULL
C.	NULL
,	NULL
Ware	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Malinin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
Wallach	NULL
,	NULL
D.	NULL
,	NULL
Yagita	NULL
,	NULL
H.	NULL
&	NULL
Okumura	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
18353-13358	NULL
Smith	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

&	NULL
Johnson	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
(	NULL
Amast	NULL
.	NULL
)	NULL

67	NULL
,	NULL
31-40	NULL
Bonnert	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Garka	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Parnet	NULL
,	NULL
P.	NULL
,	NULL
Sonoda	NULL
,	NULL
G.	NULL
,	NULL
Testa	NULL
,	NULL
J.	NULL
R.	NULL
&	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

402	NULL
,	NULL
81-84	NULL
Mosley	NULL
,	NULL
B.	NULL
,	NULL
Beckmann	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
March	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Idzerda	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Gimpel	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
VandenBos	NULL
,	NULL
T.	NULL
,	NULL
Friend	NULL
,	NULL
D.	NULL
,	NULL
Alpert	NULL
,	NULL
A.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
,	NULL
Jackson	NULL
,	NULL
J.	NULL
,	NULL
Wignall	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
,	NULL
Gallis	NULL
,	NULL
B.	NULL
,	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Urdal	NULL
,	NULL
D.	NULL
,	NULL
Widmer	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
&	NULL
Park	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
335-348	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
Wong	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

&	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
681-692	NULL
Nakano	NULL
,	NULL
H.	NULL
,	NULL
Oshima	NULL
,	NULL
H.	NULL
,	NULL
Chung	NULL
,	NULL
W.	NULL
,	NULL
Williams-Abbott	NULL
,	NULL
L.	NULL
,	NULL
Ware	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Yagita	NULL
,	NULL
H.	NULL
&	NULL
Okumura	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
14661-14664	NULL
Cao	NULL
,	NULL
Z.	NULL
,	NULL
Xiong	NULL
,	NULL
J.	NULL
,	NULL
Takeuchi	NULL
,	NULL
M.	NULL
,	NULL
Kurama	NULL
,	NULL
T.	NULL
&	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
383	NULL
,	NULL
443-446	NULL
Fanslow	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Srinivasan	NULL
,	NULL
S.	NULL
,	NULL
Paxton	NULL
,	NULL
R.	NULL
,	NULL
Gibson	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Spriggs	NULL
,	NULL
M.	NULL
K.	NULL
&	NULL
Armitage	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Semin	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
267-278	NULL
Yao	NULL
,	NULL
Z.	NULL
,	NULL
Fanslow	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Seldin	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Rousseau	NULL
,	NULL
A.-M.	NULL
,	NULL
Painter	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Comeau	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Cohen	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

&	NULL
Spriggs	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
8	NULL
,	NULL
811-821	NULL
Boucher	NULL
,	NULL
L.-M.	NULL
,	NULL
Marengéore	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Lu	NULL
,	NULL
Y.	NULL
,	NULL
Thukral	NULL
,	NULL
S.	NULL
&	NULL
Mak	NULL
,	NULL
T.	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

288	NULL
,	NULL
592-600	NULL
Cheng	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

10	NULL
,	NULL
963-973	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
9792-9796	NULL
Gires	NULL
,	NULL
O.	NULL
,	NULL
Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
Gonnella	NULL
,	NULL
R.	NULL
,	NULL
Ueffing	NULL
,	NULL
M.	NULL
,	NULL
Marschall	NULL
,	NULL
G.	NULL
,	NULL
Zeidler	NULL
,	NULL
R.	NULL
,	NULL
Pich	NULL
,	NULL
D.	NULL
&	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
6131-6140	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Birkenbach	NULL
,	NULL
M.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
VanArsdale	NULL
,	NULL
T.	NULL
,	NULL
Ware	NULL
,	NULL
C.	NULL
&	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
389-399	NULL
Devergne	NULL
,	NULL
O.	NULL
,	NULL
Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kleijnen	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
&	NULL
Mosialos	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
7098-7108	NULL
Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Devergne	NULL
,	NULL
O.	NULL
,	NULL
Harada	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
&	NULL
Mosialos	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
11085-11090	NULL
Sandberg	NULL
,	NULL
M.	NULL
,	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
&	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

71	NULL
,	NULL
4649-4656	NULL
Miller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
&	NULL
Raab-Traub	NULL
,	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

71	NULL
,	NULL
586-594	NULL
Darnay	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Haridas	NULL
,	NULL
V.	NULL
,	NULL
Ni	NULL
,	NULL
J.	NULL
,	NULL
Moore	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Aggarwal	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
20551-20555	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
The	NULL
Involvement	NULL
of	NULL
Multiple	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor	NULL
(	NULL
TNFR	NULL
)	NULL
-associated	NULL
Factors	NULL
in	NULL
the	NULL
Signaling	NULL
Mechanisms	NULL
of	NULL
Receptor	NULL
Activator	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
,	NULL
a	NULL
Member	NULL
of	NULL
the	NULL
TNFR	NULL
Superfamily	NULL
Laurent	NULL
Galibert	NULL
,	NULL
Mark	NULL
E.	NULL
Tometsko	NULL
,	NULL
Dirk	NULL
M.	NULL
Anderson	NULL
,	NULL
David	NULL
Cosman	NULL
and	NULL
William	NULL
C.	NULL
Dougall	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:34120-34127.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.51.34120	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/51/34120	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
31	NULL
references	NULL
,	NULL
18	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
20	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

